Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

October 1, 2002; Volume 43,Issue 10

Clinical Investigations

  • You have access
    Spironolactone Improves Cardiac Sympathetic Nerve Activity and Symptoms in Patients with Congestive Heart Failure
    Shu Kasama, Takuji Toyama, Hisao Kumakura, Yoshiaki Takayama, Shuichi Ichikawa, Tadashi Suzuki and Masahiko Kurabayashi
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1279-1285;
  • You have access
    Differences in Fatty Acid Metabolic Disorder Between Ischemic Myocardium and Doxorubicin-Induced Myocardial Damage: Assessment Using BMIPP Dynamic SPECT with Analysis by the Rutland Method
    Kakuya Kitagawa, Kan Takeda, Kimimasa Saito, Shinya Okamoto, Katsutoshi Makino, Hisato Maeda and Takashi Ichihara
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1286-1294;
  • You have access
    Bone Lymphoma: 67Ga Scintigraphy and CT for Prediction of Outcome After Treatment
    Ora Israel, Michal Mekel, Rachel Bar-Shalom, Ron Epelbaum, Nirit Hermony, Nissim Haim, Eldad J. Dann, Alex Frenkel, Myriam Ben-Arush and Diana Gaitini
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1295-1303;
  • You have access
    Methods to Monitor Response to Chemotherapy in Non-Small Cell Lung Cancer with 18F-FDG PET
    Corneline J. Hoekstra, Otto S. Hoekstra, Sigrid G. Stroobants, Johan Vansteenkiste, Johan Nuyts, Egbert F. Smit, Maarten Boers, Jos W.R. Twisk and Adriaan A. Lammertsma
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1304-1309;
  • You have access
    Acute Hematogenous Osteomyelitis of Children: Assessment of Skeletal Scintigraphy–Based Diagnosis in the Era of MRI
    Leonard P. Connolly, Susan A. Connolly, Laura A. Drubach, Diego Jaramillo and S. Ted Treves
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1310-1316;
  • You have access
    How to Use a Gestalt Interpretation for Ventilation-Perfusion Lung Scintigraphy
    Petronella J. Hagen, Ieneke J.C. Hartmann, Otto S. Hoekstra, Marcel P.M. Stokkel, Gerrit J.J. Teule, Martin H. Prins and ; ANTELOPE Study Group
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1317-1323;
  • You have access
    Comparative Analysis of Striatal FDOPA Uptake in Parkinson’s Disease: Ratio Method Versus Graphical Approach
    Vijay Dhawan, Yilong Ma, Vandhana Pillai, Phoebe Spetsieris, Thomas Chaly, Abdelfatihe Belakhlef, Claude Margouleff and David Eidelberg
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1324-1330;
  • You have access
    PET Imaging of Monoamine Oxidase B in Peripheral Organs in Humans
    Joanna S. Fowler, Jean Logan, Gene-Jack Wang, Nora D. Volkow, Wei Zhu, Dinko Franceschi, Naomi Pappas, Richard Ferrieri, Colleen Shea, Victor Garza, Youwen Xu, Robert R. MacGregor, David Schlyer, S. John Gatley, Yu-Shin Ding and David Alexoff
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1331-1338;

Brief Communications

  • You have access
    Focal Tracer Uptake: A Potential Artifact in Contrast-Enhanced Dual-Modality PET/CT Scans
    Gerald Antoch, Lutz S. Freudenberg, Thomas Egelhof, Jörg Stattaus, Walter Jentzen, Jörg F. Debatin and Andreas Bockisch
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1339-1342;

Continuing Education

  • You have access
    Analytic and Iterative Reconstruction Algorithms in SPECT
    Philippe P. Bruyant
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1343-1358;

Basic Science Investigations

  • You have access
    Imaging Cell Death with Radiolabeled Annexin V in an Experimental Model of Rheumatoid Arthritis
    Anneke M. Post, Peter D. Katsikis, Jonathan F. Tait, Sharon M. Geaghan, H. William Strauss and Francis G. Blankenberg
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1359-1365;
  • You have access
    Imaging Apoptosis in Rheumatoid Arthritis
    Michael W. Vannier
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1366-1367;
  • You have access
    Evaluation of a Transgenic Mouse Model for Anti-Human CEA Radioimmunotherapeutics
    Robert W. Wilkinson, Elizabeth L. Ross, David Ellison, Wolfgang Zimmermann, David Snary and Stephen J. Mather
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1368-1376;
  • You have access
    Why Certain Dyes Are Useful for Localizing the Sentinel Lymph Node
    Chris Tsopelas and Richard Sutton
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1377-1382;
  • You have access
    High-Dose 166Ho-DOTMP in Myeloablative Treatment of Multiple Myeloma: Pharmacokinetics, Biodistribution, and Absorbed Dose Estimation
    Joseph G. Rajendran, Janet F. Eary, William Bensinger, Larry D. Durack, Cheryl Vernon and Alan Fritzberg
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1383-1390;
  • You have access
    110mIn-DTPA-d-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
    Mark Lubberink, Vladimir Tolmachev, Charles Widström, Alexander Bruskin, Hans Lundqvist and Jan-Erik Westlin
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1391-1397;

Special Contributions

  • You have access
    PET Performance Measurements Using the NEMA NU 2-2001 Standard
    Margaret E. Daube-Witherspoon, Joel S. Karp, Michael E. Casey, Frank P. DiFilippo, Horace Hines, Gerd Muehllehner, Vilim Simcic, Charles W. Stearns, Lars-Eric Adam, Steve Kohlmyer and Vesna Sossi
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1398-1409;

Procedure Guidelines

  • You have access
    Procedure Guideline for Telenuclear Medicine 1.0
    J. Anthony Parker, Jerold W. Wallis, Hossein Jadvar, Paul Christian and Andrew Todd-Pokropek
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1410-1413;
  • You have access
    Procedure Guideline for Lymphoscintigraphy and the Use of Intraoperative Gamma Probe for Sentinel Lymph Node Localization in Melanoma of Intermediate Thickness 1.0
    Naomi Alazraki, Edwin C. Glass, Frank Castronovo, Renato A. Valdés Olmos and Donald Podoloff
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1414-1418;

Departments

  • You have access
    ERRATA
    Journal of Nuclear Medicine October 1, 2002, 43 (10) 1376;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 43 (10)
Journal of Nuclear Medicine
Vol. 43, Issue 10
October 1, 2002
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • Clinical Investigations
  • Brief Communications
  • Continuing Education
  • Basic Science Investigations
  • Special Contributions
  • Procedure Guidelines
  • Departments
  • Most Cited
  • Most Read
Loading
  • Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Impact of 68Ga-PSMA-11 PET/CT on Staging and Management of Prostate Cancer Patients in Various Clinical Settings: A Prospective Single-Center Study
  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study
  • Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Posttreatment SPECT/CT Scan: A Novel Methodology to Generate Time- and Tissue-Specific Dose Factors
More...
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire